Back to top
Daunotec 20 mg Injection
Daunotec 20 mg Injection

Daunotec 20 mg Injection

Daunotec 20 mg Injection Specification

  • Origin of Medicine
  • Synthetic
  • Salt Composition
  • Daunorubicin Hydrochloride
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Drug Type
  • Injection
  • Ingredients
  • Daunorubicin Hydrochloride
  • Physical Form
  • Liquid
  • Function
  • Recommended For
  • Patients undergoing treatment for leukemia or other types of cancer
  • Dosage
  • 20 mg per injection
  • Dosage Guidelines
  • Administered intravenously under the supervision of a healthcare professional
  • Suitable For
  • Adults; typically prescribed for cancer patients
  • Quantity
  • 1 vial
  • Storage Instructions
  • Store below 25C protected from light and do not freeze
 
 

About Daunotec 20 mg Injection



Daunotec 20 mg Injection is a potent synthetic anti-cancer (chemotherapy) agent used for treating various types of cancer. It comes in liquid form and is administered intravenously under the supervision of a healthcare professional. Each box contains 1 vial of Daunotec 20 mg Injection, containing Daunorubicin Hydrochloride as the active ingredient. Recommended for adults, particularly cancer patients, this injection is specifically beneficial for patients undergoing treatment for leukemia or other types of cancer. The dosage of 20 mg per injection is crucial for effective treatment. Remember to store Daunotec 20 mg Injection below 25C, protected from light, and avoid freezing.

FAQs of Daunotec 20 mg Injection:


Q: What is Daunotec 20 mg Injection used for?

A: Daunotec 20 mg Injection is an anti-cancer (chemotherapy) agent used for treating various types of cancer.

Q: How is Daunotec 20 mg Injection administered?

A: Daunotec 20 mg Injection is administered intravenously under the supervision of a healthcare professional.

Q: What is the key ingredient in Daunotec 20 mg Injection?

A: The active ingredient in Daunotec 20 mg Injection is Daunorubicin Hydrochloride.

Q: Who can use Daunotec 20 mg Injection?

A: Daunotec 20 mg Injection is suitable for adults, typically prescribed for cancer patients.

Q: How should Daunotec 20 mg Injection be stored?

A: Daunotec 20 mg Injection should be stored below 25C, protected from light, and should not be frozen.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

ACO-GTB 1000 mg Injection

ACO-GTB 1000 mg Injection

Origin of Medicine : India

Dosage Guidelines : Administer as prescribed by a healthcare professional. Typically once or twice daily depending on patient condition.

Pacakaging (Quantity Per Box) : 10 vials per box

Quantity : 1000 mg per vial

Ingredients : Paracetamol/Other Active Compounds

Recommended For : Patients experiencing severe pain fever or requiring antiinflammatory treatment

Oncofluor 250 mg Injection

Oncofluor 250 mg Injection

Origin of Medicine : Allopathic

Dosage Guidelines : Administered intravenously under medical supervision as prescribed by the doctor

Pacakaging (Quantity Per Box) : 1 vial per box

Quantity : One vial of 250 mg

Ingredients : Fluorouracil

Recommended For : Patients undergoing chemotherapy for cancers such as breast colon rectum pancreas and stomach

Sirotem Injection

Sirotem Injection

Origin of Medicine : Synthetic

Dosage Guidelines : Administered under the supervision of a healthcare provider; dosage depends on patient condition and medical advice

Pacakaging (Quantity Per Box) : 1 vial per box

Quantity : 1 vial (typically 10 mg/mL or as specified)

Ingredients : Sirolimus

Recommended For : Organ transplant patients

Innogem 200 mg Injection

Innogem 200 mg Injection

Origin of Medicine : Synthetic

Dosage Guidelines : Administered intravenously under medical supervision

Pacakaging (Quantity Per Box) : 1 vial per box

Quantity : 1 vial

Ingredients : Gemcitabine Hydrochloride

Recommended For : Patients with cancer such as breast ovarian pancreatic and nonsmall cell lung cancer